
    
      Patients with a matched donor (8/8 at molecular level unrelated donor or matched sibling)
      received an allogeneic hematopoietic stem cell transplantation.

      Patients without a matched donor received the best available treatment. All patients will be
      followed at least 36 months or until the end of the study.
    
  